Investing

When it comes to making strategic AI investment deals, companies need to articulate their competitive advantage and how they view the market around them, says Jason Smith, venture acceleration fellow at MATTER.

The oncology-focused company will use the funds to boost manufacturing capacity, grow its commercial team and develop its next-generation Amma product.

The funds will be used to expand the company's enterprise-grade platform, aiOS, and accelerate the development of CARE, a clinical-grade foundation model.

The Australian company offers its members access to AI agents that analyze their health data, lifelong health plans, whole-body testing and a personal doctor.

The funds will be used to grow the company's engineering and commercial workforce, enhance product development, and accelerate integration with payers and providers.

The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.

Plexāā, maker of the Bloom medical device for breast surgery, scores $4.5 million in funding.

The spin-off company is expected to rake in almost $2 billion in revenue this year.

The Polyphonic AI Fund for Surgery will invest in and provide mentorship to AI-enabled platforms aiming to advance surgical innovation.

The company offers mental healthcare for children and their families and will use the funds to expand its reach.